Regulatory Meetings and Correspondence. Any key meetings with a Regulatory Agency regarding a Regulatory Filing with respect to a Joint Global Study shall be conducted by the Sponsor Party for its Sponsored Territory, with prior written notification to the other Party when practicable such that the other Party will have the opportunity to be present with one (1) representative as an observer. Unless required to comply with Applicable Laws, the Party that is not the Sponsor Party shall not, without the prior written approval of the Sponsor Party, correspond or communicate with any Regulatory Agency in the applicable Sponsored Territory.
Appears in 3 contracts
Sources: Joint Clinical Collaboration Agreement (ArriVent Biopharma, Inc.), Joint Clinical Collaboration Agreement (ArriVent Biopharma, Inc.), Joint Clinical Collaboration Agreement (ArriVent Biopharma, Inc.)